Lansoprazole 30mg ( DrugBank: Lansoprazole )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 166 | Pseudoxanthoma elasticum | 1 |
166. Pseudoxanthoma elasticum
Clinical trials : 16 / Drugs : 27 - (DrugBank : 5) / Drug target genes : 5 - Drug target pathways : 28
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04660461 (ClinicalTrials.gov) | February 4, 2020 | 3/12/2020 | Response to Oral Lansoprazole of Inorganic Pyrophosphate Levels in Patients With Grönblad-Stranberg Disease (Pseudoxanthoma Elasticum) | Response to Oral Lansoprazole of Inorganic Pyrophosphate Levels in Patients With Grönblad-Stranberg Disease (Pseudoxanthoma Elasticum) | Grönblad-Stranberg Disease (Pseudoxanthoma Elasticum) | Drug: Lansoprazole 30mg;Drug: Placebo | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | NULL | Recruiting | 18 Years | N/A | All | 20 | Phase 4 | Spain |